112 related articles for article (PubMed ID: 34686999)
21. Design, synthesis and evaluation of inhibitors of the SARS-CoV-2 nsp3 macrodomain.
Sherrill LM; Joya EE; Walker A; Roy A; Alhammad YM; Atobatele M; Wazir S; Abbas G; Keane P; Zhuo J; Leung AKL; Johnson DK; Lehtiö L; Fehr AR; Ferraris D
Bioorg Med Chem; 2022 Aug; 67():116788. PubMed ID: 35597097
[TBL] [Abstract][Full Text] [Related]
22. The SARS-CoV-2 conserved macrodomain is a mono-ADP-ribosylhydrolase.
Alhammad YMO; Kashipathy MM; Roy A; Gagné JP; McDonald P; Gao P; Nonfoux L; Battaile KP; Johnson DK; Holmstrom ED; Poirier GG; Lovell S; Fehr AR
bioRxiv; 2020 Oct; ():. PubMed ID: 32511412
[TBL] [Abstract][Full Text] [Related]
23. Assessment of proton-coupled conformational dynamics of SARS and MERS coronavirus papain-like proteases: Implication for designing broad-spectrum antiviral inhibitors.
Henderson JA; Verma N; Harris RC; Liu R; Shen J
J Chem Phys; 2020 Sep; 153(11):115101. PubMed ID: 32962355
[TBL] [Abstract][Full Text] [Related]
24. Computational Bioprospecting Guggulsterone against ADP Ribose Phosphatase of SARS-CoV-2.
Kciuk M; Mujwar S; Rani I; Munjal K; Gielecińska A; Kontek R; Shah K
Molecules; 2022 Nov; 27(23):. PubMed ID: 36500379
[TBL] [Abstract][Full Text] [Related]
25. Backbone and Ile, Leu, Val methyl group resonance assignment of CoV-Y domain of SARS-CoV-2 non-structural protein 3.
Pustovalova Y; Gorbatyuk O; Li Y; Hao B; Hoch JC
Biomol NMR Assign; 2022 Apr; 16(1):57-62. PubMed ID: 34792756
[TBL] [Abstract][Full Text] [Related]
26. NMR study of non-structural proteins-part III:
Lykouras MV; Tsika AC; Lichière J; Papageorgiou N; Coutard B; Bentrop D; Spyroulias GA
Biomol NMR Assign; 2018 Apr; 12(1):31-35. PubMed ID: 28875416
[TBL] [Abstract][Full Text] [Related]
27. ADP-ribosylhydrolases: from DNA damage repair to COVID-19.
Yu L; Liu X; Yu X
J Zhejiang Univ Sci B; 2021 Jan; 22(1):21-30. PubMed ID: 33448184
[TBL] [Abstract][Full Text] [Related]
28.
Korn SM; Lambertz R; Fürtig B; Hengesbach M; Löhr F; Richter C; Schwalbe H; Weigand JE; Wöhnert J; Schlundt A
Biomol NMR Assign; 2021 Apr; 15(1):129-135. PubMed ID: 33270159
[TBL] [Abstract][Full Text] [Related]
29. Catalytic function and substrate specificity of the papain-like protease domain of nsp3 from the Middle East respiratory syndrome coronavirus.
Báez-Santos YM; Mielech AM; Deng X; Baker S; Mesecar AD
J Virol; 2014 Nov; 88(21):12511-27. PubMed ID: 25142582
[TBL] [Abstract][Full Text] [Related]
30. Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development.
Kim E; Erdos G; Huang S; Kenniston TW; Balmert SC; Carey CD; Raj VS; Epperly MW; Klimstra WB; Haagmans BL; Korkmaz E; Falo LD; Gambotto A
EBioMedicine; 2020 May; 55():102743. PubMed ID: 32249203
[TBL] [Abstract][Full Text] [Related]
31. Host ADP-ribosylation and the SARS-CoV-2 macrodomain.
Hoch NC
Biochem Soc Trans; 2021 Aug; 49(4):1711-1721. PubMed ID: 34351418
[TBL] [Abstract][Full Text] [Related]
32. Viral Macro Domains Reverse Protein ADP-Ribosylation.
Li C; Debing Y; Jankevicius G; Neyts J; Ahel I; Coutard B; Canard B
J Virol; 2016 Oct; 90(19):8478-86. PubMed ID: 27440879
[TBL] [Abstract][Full Text] [Related]
33.
Tonelli M; Rienstra C; Anderson TK; Kirchdoerfer R; Henzler-Wildman K
Biomol NMR Assign; 2021 Apr; 15(1):73-77. PubMed ID: 33219414
[TBL] [Abstract][Full Text] [Related]
34. The Enzymatic Activity of the nsp14 Exoribonuclease Is Critical for Replication of MERS-CoV and SARS-CoV-2.
Ogando NS; Zevenhoven-Dobbe JC; van der Meer Y; Bredenbeek PJ; Posthuma CC; Snijder EJ
J Virol; 2020 Nov; 94(23):. PubMed ID: 32938769
[TBL] [Abstract][Full Text] [Related]
35. Gene signatures and potential therapeutic targets of Middle East respiratory syndrome coronavirus (MERS-CoV)-infected human lung adenocarcinoma epithelial cells.
Wu YH; Yeh IJ; Phan NN; Yen MC; Hung JH; Chiao CC; Chen CF; Sun Z; Hsu HP; Wang CY; Lai MD
J Microbiol Immunol Infect; 2021 Oct; 54(5):845-857. PubMed ID: 34176764
[TBL] [Abstract][Full Text] [Related]
36. Discovery of compounds that inhibit SARS-CoV-2 Mac1-ADP-ribose binding by high-throughput screening.
Roy A; Alhammad YM; McDonald P; Johnson DK; Zhuo J; Wazir S; Ferraris D; Lehtiö L; Leung AKL; Fehr AR
Antiviral Res; 2022 Jul; 203():105344. PubMed ID: 35598780
[TBL] [Abstract][Full Text] [Related]
37. Backbone chemical shift assignments for the SARS-CoV-2 non-structural protein Nsp9: intermediate (ms - μs) dynamics in the C-terminal helix at the dimer interface.
Buchko GW; Zhou M; Craig JK; Van Voorhis WC; Myler PJ
Biomol NMR Assign; 2021 Apr; 15(1):107-116. PubMed ID: 33392924
[TBL] [Abstract][Full Text] [Related]
38.
Salvi N; Bessa LM; Guseva S; Camacho-Zarco A; Maurin D; Perez LM; Malki A; Hengesbach M; Korn SM; Schlundt A; Schwalbe H; Blackledge M
Biomol NMR Assign; 2021 Apr; 15(1):173-176. PubMed ID: 33475934
[TBL] [Abstract][Full Text] [Related]
39. MERS-CoV and SARS-CoV-2 replication can be inhibited by targeting the interaction between the viral spike protein and the nucleocapsid protein.
Park BK; Kim J; Park S; Kim D; Kim M; Baek K; Bae JY; Park MS; Kim WK; Lee Y; Kwon HJ
Theranostics; 2021; 11(8):3853-3867. PubMed ID: 33664866
[No Abstract] [Full Text] [Related]
40. NMR study of non-structural proteins--part II: (1)H, (13)C, (15)N backbone and side-chain resonance assignment of macro domain from Venezuelan equine encephalitis virus (VEEV).
Makrynitsa GI; Ntonti D; Marousis KD; Tsika AC; Lichière J; Papageorgiou N; Coutard B; Bentrop D; Spyroulias GA
Biomol NMR Assign; 2015 Oct; 9(2):247-51. PubMed ID: 25291978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
